Mavrilimumab
- Generic Name
- Mavrilimumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1085337-57-0
- Unique Ingredient Identifier
- 1158JD1P9A
- Background
Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath